Established in 1970, Zhejiang Haizhou Pharmaceutical Co. Ltd. is a leading pharmaceutical company, with a focus on the manufacture and supply of specialized pharmaceutical raw materials and fine chemicals. Located in the Yanhai Industrial Park (one of the most prominent pharmaceutical industrial zones in China), our site has a footprint of 35 acres (133,000m2).
Our expertise in Production and Logistics, along with our compliance to current market standards, translate to the efficient Global supply of Active Pharmaceutical Ingredients (API), Intermediates, fine chemicals and Custom Manufacturing Services. We offer three key product segments: Guaiacol derivatives, Epichlorohydrin derivatives and Iodine contrast medias.
In terms of Quality, Haizhou Pharm is ISO9001/14001 and OHSAS18001 approved, with the ISO/OHSAS management philosophy running deeply through our processes and company structure. Our API production is also aligned with cGMP standards, being approved by the NMPA (China FDA), US-FDA and EDQM respectively.
With a professional contract manufacturing project team running and managing multi-functional workshops, Haizhou Pharma is dedicated to quality and accuracy. Over many years, this has translated to long-standing partnerships with numerous global pharmaceutical enterprises (such as GSK, GE Healthcare and Pfizer), providing contract services under both GMP and nonGMP conditions.
Trust and transparency are prioritised within all our partnerships and business relationships, to ensure clarity, alignment and delivery.